12-49188973-TC-T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_006009.4(TUBA1A):c.3+3delG variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_006009.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUBA1A | NM_006009.4 | c.3+3delG | splice_region_variant, intron_variant | Intron 1 of 3 | ENST00000301071.12 | NP_006000.2 | ||
TUBA1A | NM_001270399.2 | c.-555delG | 5_prime_UTR_variant | Exon 1 of 4 | NP_001257328.1 | |||
TUBA1A | NM_001270400.2 | c.-188delG | 5_prime_UTR_variant | Exon 1 of 4 | NP_001257329.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Lissencephaly due to TUBA1A mutation Pathogenic:2
The vast majority of transcripts derived from c.3+3del variant allele use the least frequently utilized 5’-splice site at Chr12:g.49582671 for exon 1-2 splicing, removing 35 highly conserved amino acids from the N-terminus of tubulin alpha 1-A chain (Figure 6). The overall consequence of the c.3+3del variant is loss of expression of the predominant TUBA1A isoform expressed in brain and all tissues examined, which is likely to be associated with haploinsufficiency of the predominant isoform of Tubulin alpha-1A chain. It is clear the encoded 35 residues encoded in this isoform are functionally important, with 7 of these 35 amino acids are classified as pathogenic variants associated with lissencephaly in ClinVar or LOVD. -
Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as Likely Pathogenic. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0104 - Dominant Negative is a mechanism of disease for this gene. (N) 0107 - This gene is known to be associated with autosomal dominant disease. (N) 0209 - Splice variant (canonical or non-canonical) proven to affect splicing/expression of the transcript with uncertain effect on protein structure. RT-PCR studies have shown that this variant results in loss of the main isoform in brain and the use of an alternative criptic site. This is predicted to result in a deletion of the first 35 residues of the protein, p.(Met1_Gln35del) (personal communication). (P) 0251 - Variant is heterozygous. (N) 0301 - Variant is absent from gnomAD. (P) 0309 - A nucleotide change at the same position has been observed in gnomAD (2 heterozygous, 0 homozygous). (N) 0508 - In silico predictions for abnormal splicing are conflicting. (N) 0705 - No comparable variants have previous evidence for pathogenicity. (N) 0807 - Variant has not previously been reported in a clinical context. (N) 0905 - No segregation evidence has been identified for this variant. (N) 1007 - No published functional evidence has been identified for this variant. (N) 1204 - Variant shown to be de novo in proband (parental status not tested but assumed). (P) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.